Abstract 437P
Background
Physician burnout negatively affects patient care, incurs added costs, and compromises the physician’s own safety. In the field of Medical Oncology, the demands entailed in caring for cancer patients combined with broader pressures on the healthcare system may present significant challenges for both physicians and nurses, including the risk for burnout. This study aims to determine the prevalence of burnout among Medical Oncology fellows-in-training in the Philippines, as well as identify which of the domains of burnout are commonly experienced by the fellows-in-training.
Methods
This is a descriptive cross-sectional study evaluating the prevalence of burnout among Medical Oncology fellows-in-training using the Maslach Burnout Inventory (MBI).
Results
Out of 70 Medical Oncology fellows-in-training, 50 participated in the survey. Most of the fellows-in-training were experiencing some degree of burnout during the conduct of the study. Fifty four percent (27) felt a high level of emotional exhaustion, while 38% (19) and 42% (21) felt a moderate level of burnout in the depersonalization and personal accomplishment domains respectively. Overall, 94% of respondents had a moderate to high level of burnout.
Conclusions
Physician burnout remains to be a considerable problem among Medical Oncology fellows-in-training in the Philippines. Majority of respondents experienced a moderate to high level of burnout, most commonly in the emotional exhaustion domain. Vacation leaves, recreational and wellness activities, and decreased work hours are some of the interventions cited to help reduce physician burnout.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
440P - Targeting KRAS<sup>G12C</sup>: Repurposing of potential therapeutics for the treatment of pancreatic ductal adenocarcinoma (PDAC)
Presenter: EVA RAHMAN KABIR
Session: Poster viewing 06
441P - Malignant diseases diagnosed in people living with HIV in Japan
Presenter: Kenju Ando
Session: Poster viewing 06
442P - Dose intensity and tolerance of modified FOLFIRINOX in patients with advanced cancer
Presenter: Tejaswini Adadadara
Session: Poster viewing 06
444P - Incidence of cancer diagnosis and cancer care before and after the COVID-19 pandemic in French Polynesia TEAHUPOO study
Presenter: Elodie HIRIGOYEN
Session: Poster viewing 06
445P - Development of a simple and objective prognostication model in patients with advanced solid malignant tumor treated with immune checkpoint inhibitors: A pan-cancer analysis
Presenter: Yuto Matsushita
Session: Poster viewing 06
446P - Impact of previous immunotherapy on chemotherapy efficacy in metastatic melanoma
Presenter: Meiyu Fang
Session: Poster viewing 06
447P - Clinical characteristics of 21 patients with type 1 diabetes mellitus related to immune checkpoint inhibitors
Presenter: Haruna Kameoka
Session: Poster viewing 06
448P - Prevalence of thyroid dysfunction, diabetes, and impact of palliative chemotherapy in advanced metastatic cancer patients: Prospective data from LMIC
Presenter: Amit Sehrawat
Session: Poster viewing 06
449P - The study of androgen receptor status in triple negative breast cancer patients at Medical Oncology Department, Yangon General Hospital (YGH)
Presenter: Khin Mu
Session: Poster viewing 06
450P - Are grade III well-differentiated neuroendocrine tumours a unique clinic-pathological entity?
Presenter: Jahnavi Kalvala
Session: Poster viewing 06